Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Abolishing medical indication patents could hinder innovation in medicine.

Choose treatments for sex offenders based on individual needs, using hormonal and nonhormonal options to reduce sexual drive.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Choosing the right recall period for patient feedback is important for accurate data and depends on the disease, symptom changes, and patient impact.

Drug repurposing offers a faster, cheaper way to find treatments for rare diseases.

Smart microneedles using advanced tech could improve psoriasis treatment.

Patients with skin immune diseases need better education on UV protection to improve compliance.

Combination therapies might work better for some vitiligo patients, but results vary.

Patients with non-small-cell lung cancer need significant survival gains to accept severe side effects.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

IL-1 blockade is effective for treating SURF, and personalized treatment is needed.

Drug repurposing offers faster, cheaper drug development but faces challenges like safety, ethics, and funding.

Patients with alopecia areata prefer effective, safe, and convenient treatments, especially topical ones.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

Injectable biomaterials show promise for treating spinal degeneration but need better design for effective use.

Systematic symptom assessment helps prioritize care for children undergoing cancer treatment.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Aesthetic rehabilitation techniques can improve life quality and wellbeing for disabled patients.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Composite biomaterials can precisely control immune responses for better disease treatment.

Microneedles can precisely deliver cancer treatments with fewer side effects.

Tailoring facelift techniques to individual needs improves patient satisfaction.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Some alternative therapies might help treat eating disorders when combined with standard care, but more research is needed to confirm their safety and effectiveness.

Advanced hydrogels can autonomously deliver drugs to treat radiation skin injuries, but challenges remain for clinical use.